Page last updated: 2024-08-16

ranitidine and Granulocytic Leukemia, Chronic

ranitidine has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assa'ad, A; Burns, K; Hershey, GK; Johnson, T; Lierl, MB; Metz, KA; Seidu, L1
Brune, M; Dahlgren, C; Hansson, M; Hellstrand, K; Hermodsson, S; Mellqvist, UH1

Other Studies

2 other study(ies) available for ranitidine and Granulocytic Leukemia, Chronic

ArticleYear
Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 102, Issue:2

    Topics: Cytarabine; Diphenhydramine; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylprednisolone; Premedication; Ranitidine; Syndrome; Treatment Outcome

2009
Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine.
    Blood, 2000, Sep-01, Volume: 96, Issue:5

    Topics: Apoptosis; Catalase; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Histamine; Humans; Interleukin-2; K562 Cells; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutrophils; Ranitidine; Reactive Oxygen Species; T-Lymphocyte Subsets

2000